Overview

• The reported measure targets branded and patented pharmaceutical products shipped from the United States to India, with implementation scheduled for October 1.
• Maharashtra Deputy Chief Minister Ajit Pawar said India should make its own decisions in its people’s interest and respond to the U.S. move in a dignified manner.
• Pawar invoked Mahatma Gandhi’s Swadeshi call and noted Prime Minister Narendra Modi has reiterated the message, urging greater use of domestically made goods.
• India’s pharma sector supplies over half of global vaccine demand, about 40% of U.S. generics, and a quarter of medicines in the UK, according to government-cited data.
• Exports reached a record USD 30 billion in FY25, August shipments rose 6.94% year on year, and official reports project industry growth to USD 130 billion by 2030 and USD 450 billion by 2047.